BANK OF AMERICA CORP /DE/
BankPosition in PTGX — Protagonist Therapeutics, Inc
CIK 70858
CHARLOTTE, NC
Position in PTGX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$162,356,963
+$25,818,221 QoQ
Shares Held
1,324,498
+2.2% QoQ
Ownership
2.05%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#15
of 341 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 90%
Shared 0%
None 10%
Common Shares in PTGX Over Time
Shares Held
Position Value (USD)
Derivatives in PTGX
reported options exposure · as of Mar 31, 2025CallValue
$2,176,200
CallShares
45,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026BANK OF AMERICA CORP /DE/ holds $10,050,306,032 across 338 Biotechnology names. PTGX ranks #12 (1.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,039,178 | $1,509,650,884 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,291,053 | $805,023,185 | |
| 3 | CYTK |
Cytokinetics Inc
|
4,635,709 | $394,916,048 | |
| 4 | ARGX |
Argenx SE
|
400,234 | $371,325,094 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
994,476 | $299,367,107 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
1,136,091 | $273,763,844 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
4,568,341 | $259,527,450 | |
| 8 | RPRX |
Royalty Pharma plc
|
4,149,422 | $232,658,090 |
All Filings in PTGX
Export CSV
27 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $162,356,963 | 1,324,498 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $136,538,742 | 1,295,434 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $75,774,433 | 867,580 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $55,128,725 | 829,877 | Shares | Defined | 2026-02-03 | |
| 2025-06-30 | $47,080,751 | 851,832 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $2,176,200 | 45,000 | Call | Defined | 2025-05-15 | |
| 2025-03-31 | $22,813,586 | 471,745 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $5,206,058 | 134,872 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $1,557,675 | 34,615 | Shares | Defined | 2025-03-18 | |
| 2024-06-30 | $10,411,665 | 300,481 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $1,102,550 | 38,111 | Shares | Defined | 2025-03-18 | |
| 2023-12-31 | $3,517,667 | 153,409 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $3,987,152 | 239,038 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $8,182,147 | 296,240 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $17,640,770 | 766,990 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $3,763,371 | 344,947 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $2,613,711 | 310,049 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $2,430,188 | 307,230 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $5,869,702 | 247,876 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $4,090,558 | 119,607 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $1,021,574 | 57,651 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $2,950,095 | 65,733 | Shares | Defined | 2021-09-13 | |
| 2021-03-31 | $1,080,417 | 41,715 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $270,607 | 13,423 | Shares | Defined | 2021-02-10 | |
| 2020-09-30 | $1,190,065 | 60,873 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $129,182 | 7,315 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $54,912 | 7,778 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||